Bourgeon Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,150	Closed	-$66.6K	–	339
2023 Q1	$66.6K	Buy	4,150 +1,500	+57%	+$24.1K	0.02%	132
2022 Q4	$48.5K	Buy	+2,650	New	+$48.5K	0.01%	155